跳至主要内容
临床试验/JPRN-UMIN000035972
JPRN-UMIN000035972招募中1 期

Subtotal integumentectomy for treatment of malignant melanoma with indocyanine green(ICG) - Subtotal integumentectomy for treatment of malignant melanoma

Faculty of Life Sciences, Kumamoto University0 个研究点目标入组 10 人开始时间: 2019年2月22日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Subjects have a history of severe hypersensitivity and side effects in Indocyanine green (ICG). Subjects suffer from malignant tumors within 5 years. Subjects suffer from acute myocardial infarction, unstable angina, myocarditis, cerebral infarction within 3 months. Subjects have remarkably unstable circulation dynamics due to severe heart failure, arrhythmia, etc. Subject has active infection. Subjects may be pregnant or pregnant Subject's serum albumin is less than 2g/dl. We can not identify lymph flow with ICG during surgery. In addition, when the doctor in charge judges the subject as inappropriate.

研究者

发起方
Faculty of Life Sciences, Kumamoto University

相似试验